glp 1 gip glucagon retatrutide ly3437943 triple agonist glp-1 mechanism Beyond -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based A Dual GLP-1/GIP Receptor Agonist

cAMP formation initiates several downstream signaling pathways by activating downstream effector proteins such as protein kinase A (PKA) and exchange protein (Epac) activated by cAMP [31, 32]

Ridker PM, Bhatt DL, Pradhan AD, Glynn RJ, MacFadyen JG, Nissen SE (2023) Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Circana data indicates that households indexed higher on active shorts, casual pants, jeans, bras, and dresses during their first year of GLP1 use, compared to before treatment began

Related article: GLP1 Injection Sites: Where to Inject Your Medication and Where Not To

Nutrients , 15(22), 4809

Many GLP-1 boosting supplements contain prebiotic fiber that promotes SCFA production (like butyrate), which can stimulate GLP-1 release in the colon